Kiernan P D, Sheridan M J, Byrne W D, Fulcher T M, Conte J, Corcoran P C, Pagani F, Seigel L
Section of Thoracic Surgery, Fairfax Hospital.
Va Med Q. 1993 Winter;120(1):33-6.
Between January 1, 1981 and December 31, 1989, 222 patients with carcinoma of the esophagus were seen at Fairfax Hospital. Fifty-eight (26.1%) underwent esophagogastrectomy. Operative (30-day) mortality was 8.6%. Follow-up was 98.3% complete. Of hospital survivors, 38 (76%) were resected for potential cure versus 12 (24%) for palliation. Consistent with the experience of others, a minority of patients (26%) presented with early (Stage I & II) disease; forty patients (69%) were noted to be Stage III or IV at time of resection and three patients (5%) were stage indeterminant. The five year Kaplan-Meier product limit survival estimate for Stage II patients was 52%, versus 22% for stage III, and 0% for Stage IV.
1981年1月1日至1989年12月31日期间，费尔法克斯医院共收治了222例食管癌患者。其中58例（26.1%）接受了食管胃切除术。手术（30天）死亡率为8.6%。随访完成率为98.3%。在医院幸存者中，38例（76%）接受手术切除以期治愈，12例（24%）接受手术以缓解症状。与其他研究经验一致，少数患者（26%）表现为早期（I期和II期）疾病；40例（69%）在切除时被诊断为III期或IV期，3例（5%）分期不确定。II期患者的五年Kaplan-Meier乘积限生存估计值为52%，III期为22%，IV期为0%。
